April 8, 2020 Price forecast | 2 weeks: 0.81% | 1 month: -0.21% | 3 months: 2.33%


NGM stock forecast

Our latest prediction for NGM Biopharmaceuticals, Inc.'s stock price was made on the April 8, 2020 when the stock price was at 15.04$.

In the short term (2weeks), NGM's stock price should outperform the market by 0.81%. During that period the price should oscillate between -9.36% and +12.87%.

In the medium term (3months), NGM's stock price should outperform the market by 2.33%. During that period the price should oscillate between -22.54% and +31.74%.

Create a solid portfolio with NGM

Add NGM to your portfolio and optimize it!


About NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Its portfolio include aldafermin (NGM282), NGM313, NGM120, NGM217, NGM621, and NGM395. The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA.

At the moment the company generates 102M USD in revenues.

On its last earning announcement, the company reported a loss of -1.00$ per share.

The book value per share is 2.88$

NGM Biopharmaceuticals, Inc. website


Three months stock forecastApril 8, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
102M - -61M -59.30% -54M -1.00 - - 68M 2.88 -48M -2M -50M